Auris Medical Holding Ltd (EARS):企業の財務・戦略的SWOT分析

◆英語タイトル:Auris Medical Holding Ltd (EARS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH134156FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:バミューダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Auris Medical Holding Ltd (EARS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Auris Medical Holding Ltd (Auris Medical) is a clinical-stage biopharmaceutical company with focus on neurotology and CNS disorders. The company’s pipeline product candidates are in various clinical phases intended for the treatment of acute inner ear tinnitus, post-acute inner ear tinnitus, tinnitus, Vertigo, sudden loss of hearing, antipsychotic-induced weight gain and somnolence. It has research collaboration and licensing agreements with research institutions such as King’s College London, Pharmaceutical and Biotechnology companies including Xigen and Inserm. Auris Medical is headquartered in Hamilton, Bermuda.

Auris Medical Holding Ltd Key Recent Developments

Sep 17,2020: Auris Medical provides business update and reports first half 2020 financial results
Apr 16,2020: Auris Medical provides business update and reports second half and full year 2019 financial results
Dec 30,2019: Auris Medical announces formation of new subsidiary for development projects in tinnitus and hearing loss
Sep 04,2019: Auris Medical announces appointment of new Chief Financial Officer
Aug 15,2019: Auris Medical provides business update and reports first half 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Auris Medical Holding Ltd – Key Facts
Auris Medical Holding Ltd – Key Employees
Auris Medical Holding Ltd – Key Employee Biographies
Auris Medical Holding Ltd – Major Products and Services
Auris Medical Holding Ltd – History
Auris Medical Holding Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Auris Medical Holding Ltd – Business Description
R&D Overview
Auris Medical Holding Ltd – Corporate Strategy
Auris Medical Holding Ltd – SWOT Analysis
SWOT Analysis – Overview
Auris Medical Holding Ltd – Strengths
Auris Medical Holding Ltd – Weaknesses
Auris Medical Holding Ltd – Opportunities
Auris Medical Holding Ltd – Threats
Auris Medical Holding Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Auris Medical Holding Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 17, 2020: Auris Medical provides business update and reports first half 2020 financial results
Apr 16, 2020: Auris Medical provides business update and reports second half and full year 2019 financial results
Dec 30, 2019: Auris Medical announces formation of new subsidiary for development projects in tinnitus and hearing loss
Sep 04, 2019: Auris Medical announces appointment of new Chief Financial Officer
Aug 15, 2019: Auris Medical provides business update and reports first half 2019 financial results
May 23, 2019: Auris Medical Holding provides corporate update
Mar 14, 2019: Auris Medical provides business update and reports fourth quarter and full year 2018 financial results
Feb 01, 2019: Auris Medical announces full repayment of Hercules loan facility
Jan 29, 2019: Auris Medical to Redomicile Holding Company from Switzerland to Bermuda
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Auris Medical Holding Ltd, Key Facts
Auris Medical Holding Ltd, Key Employees
Auris Medical Holding Ltd, Key Employee Biographies
Auris Medical Holding Ltd, Major Products and Services
Auris Medical Holding Ltd, History
Auris Medical Holding Ltd, Subsidiaries
Auris Medical Holding Ltd, Key Competitors
Auris Medical Holding Ltd, Ratios based on current share price
Auris Medical Holding Ltd, Annual Ratios
Auris Medical Holding Ltd, Annual Ratios (Cont...1)
Auris Medical Holding Ltd, Interim Ratios
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Auris Medical Holding Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Auris Medical Holding Ltd (EARS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析
    R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • OJSC AK BARS Bank:企業の戦略・SWOT・財務情報
    OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report Summary OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Brambles Limited:企業の戦略・SWOT・財務分析
    Brambles Limited - Strategy, SWOT and Corporate Finance Report Summary Brambles Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • Sri Lanka Telecom PLC (SLTL.N0000):企業の財務・戦略的SWOT分析
    Sri Lanka Telecom PLC (SLTL.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • ALSO Holding AG:企業の戦略・SWOT・財務情報
    ALSO Holding AG - Strategy, SWOT and Corporate Finance Report Summary ALSO Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • GNC Holdings, Inc.:企業の戦略・SWOT・財務分析
    GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aerpio Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aerpio Therapeutics Inc (Aerpio) is a biopharmaceutical company that develops novel monoclonal antibodies and small molecules. The company’s programs include a Tie-2 activator for diabetic macular edema and a hypoxia-inducible factor stabilizer for the treatment of inflammatory bowel disease …
  • Saskatchewan Telecommunications Holding Corporation:企業の戦略的SWOT分析
    Saskatchewan Telecommunications Holding Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • Spherix Inc (SPEX):企業の財務・戦略的SWOT分析
    Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Coeur Mining, Inc:企業のM&A・事業提携・投資動向
    Coeur Mining, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coeur Mining, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Southern California Edison Co:企業の発電所・SWOT分析2018
    Southern California Edison Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Universal Biosensors Inc (UBI)-医療機器分野:企業M&A・提携分析
    Summary Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the …
  • FirstEnergy Corp:企業の発電所・SWOT分析2018
    FirstEnergy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Carmell Therapeutics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio include adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for total j …
  • Nutritional Resources Inc:企業の戦略・SWOT・財務情報
    Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report Summary Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Lundin Petroleum AB (LUPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lundin Petroleum AB (Lundin Petroleum) is an independent oil and gas exploration and production company that acquires, explores, develops and produces oil and gas properties in Norway. The company identifies and matures exploration targets, drill exploration wells, appraise discoveries, and …
  • Saint-Gobain Weber GmbH:企業の戦略・SWOT・財務分析
    Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report Summary Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Endocyte Inc (ECYT):企業の財務・戦略的SWOT分析
    Summary Endocyte Inc (Endocyte) is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline products include Lu-PSMA-617 and Ac-PSMA-617 for radiologand therapy, and FITC CAR-T. Endocyte's proprietary small molecule dr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆